Akebia Capex To Operating Cash Flow vs Price To Sales Ratio Analysis

AKBA Stock

USD 2.13 0.01 0.47%

Akebia Ther financial indicator trend analysis is way more than just evaluating Akebia Ther prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Akebia Ther is a good investment. Please check the relationship between Akebia Ther Capex To Operating Cash Flow and its Price To Sales Ratio accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akebia Ther. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For information on how to trade Akebia Stock refer to our How to Trade Akebia Stock guide.

Capex To Operating Cash Flow vs Price To Sales Ratio

Capex To Operating Cash Flow vs Price To Sales Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Akebia Ther Capex To Operating Cash Flow account and Price To Sales Ratio. At this time, the significance of the direction appears to have weak relationship.

The correlation between Akebia Ther's Capex To Operating Cash Flow and Price To Sales Ratio is 0.39. Overlapping area represents the amount of variation of Capex To Operating Cash Flow that can explain the historical movement of Price To Sales Ratio in the same time period over historical financial statements of Akebia Ther, assuming nothing else is changed. The correlation between historical values of Akebia Ther's Capex To Operating Cash Flow and Price To Sales Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Operating Cash Flow of Akebia Ther are associated (or correlated) with its Price To Sales Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price To Sales Ratio has no effect on the direction of Capex To Operating Cash Flow i.e., Akebia Ther's Capex To Operating Cash Flow and Price To Sales Ratio go up and down completely randomly.

Correlation Coefficient

0.39

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Capex To Operating Cash Flow

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Akebia Ther stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Akebia Ther sales, a figure that is much harder to manipulate than other Akebia Ther multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Most indicators from Akebia Ther's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Akebia Ther current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akebia Ther. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For information on how to trade Akebia Stock refer to our How to Trade Akebia Stock guide.The current year's Enterprise Value is expected to grow to about 394.5 M, whereas Selling General Administrative is forecasted to decline to about 3.5 M.

	2022	2023	2024	2025 (projected)
Interest Expense	15.7M	6.0M	6.9M	9.4M
Depreciation And Amortization	35.3M	37.6M	43.3M	45.4M

Interest Expense Depreciation And Amortization

Akebia Ther fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Other Current Assets	Total Liab	Total Current Assets	Common Stock	Short Long Term Debt Total	Property Plant And Equipment Net	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Non Current Liabilities Total	Other Stockholder Equity	Property Plant And Equipment Gross	Short Term Debt
Total Assets		0.96	0.93	0.82	-0.3	-0.44	0.93	0.71	0.7	0.49	0.39	0.52	0.46	0.83	0.91	0.19	0.49	0.62	0.93	0.72	0.4	0.82	0.62	0.65	0.44	0.3
Other Current Liab	0.96		0.95	0.68	-0.12	-0.62	0.98	0.69	0.57	0.57	0.55	0.67	0.62	0.91	0.83	0.27	0.69	0.76	0.94	0.77	0.5	0.84	0.76	0.79	0.61	0.43
Total Current Liabilities	0.93	0.95		0.61	-0.22	-0.6	0.9	0.73	0.65	0.66	0.46	0.63	0.64	0.94	0.88	0.28	0.64	0.72	0.85	0.73	0.63	0.66	0.76	0.75	0.62	0.56
Total Stockholder Equity	0.82	0.68	0.61		-0.51	0.1	0.68	0.47	0.69	0.05	-0.09	0.0	0.0	0.4	0.72	0.0	0.01	0.2	0.78	0.5	0.07	0.72	0.12	0.19	-0.02	-0.09
Net Debt	-0.3	-0.12	-0.22	-0.51		-0.44	-0.1	-0.62	-0.76	0.04	0.59	0.47	0.32	-0.08	-0.51	0.03	0.34	0.13	-0.07	-0.02	0.15	-0.2	0.08	0.25	0.17	0.29
Retained Earnings	-0.44	-0.62	-0.6	0.1	-0.44		-0.59	-0.38	-0.02	-0.77	-0.92	-0.96	-0.89	-0.79	-0.34	-0.25	-0.92	-0.8	-0.47	-0.47	-0.56	-0.38	-0.91	-0.93	-0.84	-0.67
Accounts Payable	0.93	0.98	0.9	0.68	-0.1	-0.59		0.68	0.49	0.5	0.51	0.63	0.59	0.86	0.75	0.22	0.71	0.79	0.95	0.83	0.53	0.87	0.71	0.75	0.63	0.44
Cash	0.71	0.69	0.73	0.47	-0.62	-0.38	0.68		0.72	0.56	0.15	0.32	0.36	0.75	0.78	0.17	0.51	0.64	0.54	0.61	0.35	0.62	0.67	0.51	0.54	0.27
Cash And Short Term Investments	0.7	0.57	0.65	0.69	-0.76	-0.02	0.49	0.72		0.35	-0.13	0.03	0.11	0.53	0.9	0.04	0.04	0.17	0.42	0.24	0.1	0.46	0.32	0.24	0.14	0.0
Net Receivables	0.49	0.57	0.66	0.05	0.04	-0.77	0.5	0.56	0.35		0.59	0.72	0.72	0.79	0.53	0.35	0.74	0.69	0.39	0.48	0.53	0.23	0.83	0.81	0.65	0.6
Common Stock Total Equity	0.39	0.55	0.46	-0.09	0.59	-0.92	0.51	0.15	-0.13	0.59		0.97	0.76	0.64	0.24	0.23	0.77	0.62	0.48	0.35	0.34	0.39	0.76	0.85	0.62	0.47
Common Stock Shares Outstanding	0.52	0.67	0.63	0.0	0.47	-0.96	0.63	0.32	0.03	0.72	0.97		0.84	0.78	0.39	0.26	0.86	0.74	0.56	0.48	0.5	0.44	0.86	0.92	0.74	0.6
Other Current Assets	0.46	0.62	0.64	0.0	0.32	-0.89	0.59	0.36	0.11	0.72	0.76	0.84		0.78	0.36	0.22	0.81	0.76	0.48	0.38	0.72	0.29	0.83	0.89	0.91	0.83
Total Liab	0.83	0.91	0.94	0.4	-0.08	-0.79	0.86	0.75	0.53	0.79	0.64	0.78	0.78		0.78	0.31	0.82	0.84	0.76	0.7	0.6	0.64	0.94	0.89	0.77	0.6
Total Current Assets	0.91	0.83	0.88	0.72	-0.51	-0.34	0.75	0.78	0.9	0.53	0.24	0.39	0.36	0.78		0.15	0.35	0.47	0.7	0.51	0.3	0.65	0.58	0.53	0.37	0.21
Common Stock	0.19	0.27	0.28	0.0	0.03	-0.25	0.22	0.17	0.04	0.35	0.23	0.26	0.22	0.31	0.15		0.24	0.23	0.21	0.18	0.14	0.18	0.3	0.22	0.21	0.15
Short Long Term Debt Total	0.49	0.69	0.64	0.01	0.34	-0.92	0.71	0.51	0.04	0.74	0.77	0.86	0.81	0.82	0.35	0.24		0.93	0.55	0.7	0.6	0.51	0.91	0.91	0.85	0.66
Property Plant And Equipment Net	0.62	0.76	0.72	0.2	0.13	-0.8	0.79	0.64	0.17	0.69	0.62	0.74	0.76	0.84	0.47	0.23	0.93		0.67	0.82	0.62	0.61	0.86	0.82	0.87	0.64
Non Current Assets Total	0.93	0.94	0.85	0.78	-0.07	-0.47	0.95	0.54	0.42	0.39	0.48	0.56	0.48	0.76	0.7	0.21	0.55	0.67		0.8	0.43	0.85	0.57	0.66	0.44	0.33
Non Currrent Assets Other	0.72	0.77	0.73	0.5	-0.02	-0.47	0.83	0.61	0.24	0.48	0.35	0.48	0.38	0.7	0.51	0.18	0.7	0.82	0.8		0.54	0.66	0.58	0.57	0.49	0.42
Other Assets	0.4	0.5	0.63	0.07	0.15	-0.56	0.53	0.35	0.1	0.53	0.34	0.5	0.72	0.6	0.3	0.14	0.6	0.62	0.43	0.54		0.06	0.5	0.55	0.72	0.96
Long Term Debt	0.82	0.84	0.66	0.72	-0.2	-0.38	0.87	0.62	0.46	0.23	0.39	0.44	0.29	0.64	0.65	0.18	0.51	0.61	0.85	0.66	0.06		0.55	0.56	0.38	-0.02
Non Current Liabilities Total	0.62	0.76	0.76	0.12	0.08	-0.91	0.71	0.67	0.32	0.83	0.76	0.86	0.83	0.94	0.58	0.3	0.91	0.86	0.57	0.58	0.5	0.55		0.94	0.82	0.57
Other Stockholder Equity	0.65	0.79	0.75	0.19	0.25	-0.93	0.75	0.51	0.24	0.81	0.85	0.92	0.89	0.89	0.53	0.22	0.91	0.82	0.66	0.57	0.55	0.56	0.94		0.79	0.62
Property Plant And Equipment Gross	0.44	0.61	0.62	-0.02	0.17	-0.84	0.63	0.54	0.14	0.65	0.62	0.74	0.91	0.77	0.37	0.21	0.85	0.87	0.44	0.49	0.72	0.38	0.82	0.79		0.8
Short Term Debt	0.3	0.43	0.56	-0.09	0.29	-0.67	0.44	0.27	0.0	0.6	0.47	0.6	0.83	0.6	0.21	0.15	0.66	0.64	0.33	0.42	0.96	-0.02	0.57	0.62	0.8

Click cells to compare fundamentals

Akebia Ther Account Relationship Matchups

Akebia Ther fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	644.1M	525.6M	351.8M	241.7M	278.0M	411.2M
Other Current Liab	125.3M	104.2M	71.0M	61.2M	70.4M	67.9M
Total Current Liabilities	187.1M	256.5M	124.8M	99.9M	114.9M	130.9M
Total Stockholder Equity	247.6M	76.5M	9.3M	(30.6M)	(35.2M)	(33.4M)
Net Debt	(102.4M)	(13.8M)	9.3M	61.3M	70.4M	74.0M
Retained Earnings	(1.2B)	(1.5B)	(1.6B)	(1.6B)	(1.4B)	(1.4B)
Accounts Payable	41.3M	33.6M	18.0M	14.6M	16.8M	18.7M
Cash	228.7M	149.8M	90.5M	42.9M	49.4M	46.9M
Cash And Short Term Investments	268.7M	149.8M	90.5M	42.9M	49.4M	46.9M
Net Receivables	26.9M	51.6M	41.1M	39.3M	45.2M	28.3M
Common Stock Shares Outstanding	138.5M	165.9M	182.8M	187.5M	215.6M	226.4M
Liabilities And Stockholders Equity	644.1M	525.6M	351.8M	241.7M	278.0M	411.2M
Other Current Assets	14.9M	33.1M	32.9M	20.2M	23.3M	12.6M
Total Liab	396.5M	449.1M	342.5M	272.3M	313.1M	247.7M
Total Current Assets	371.4M	272.0M	184.9M	118.1M	135.9M	244.4M
Short Long Term Debt Total	126.3M	136.0M	99.8M	104.2M	119.8M	72.1M
Property Plant And Equipment Net	35.5M	40.6M	34.4M	16.0M	18.5M	18.1M
Non Current Assets Total	272.7M	253.5M	166.9M	123.6M	142.1M	182.0M
Non Currrent Assets Other	38.0M	49.8M	5.4M	12.4M	14.3M	20.8M
Other Assets	76.0M	64.9M	640.3M	94.5M	108.7M	112.1M
Long Term Debt	98.8M	1.8M	34.1M	17.2M	19.8M	25.2M
Non Current Liabilities Total	209.4M	192.6M	217.7M	172.4M	198.3M	127.4M
Other Stockholder Equity	1.4B	1.5B	1.6B	1.6B	1.8B	973.5M
Property Plant And Equipment Gross	35.5M	48.3M	43.7M	16.0M	18.5M	16.9M
Accumulated Other Comprehensive Income	(261K)	0.0	13K	6K	6.9K	7.2K
Short Term Debt	5.3M	102.3M	36.7M	24.0M	27.6M	20.8M
Property Plant Equipment	10.4M	8.6M	6.8M	5.2M	6.0M	5.1M
Other Liab	65.0M	88.4M	158.9M	158.2M	182.0M	95.8M
Net Tangible Assets	48.5M	48.4M	(86.7M)	(117.8M)	(106.0M)	(100.7M)
Retained Earnings Total Equity	(794.1M)	(1.2B)	(1.5B)	(1.6B)	(1.4B)	(1.3B)
Capital Surpluse	1.2B	1.4B	1.5B	1.6B	1.8B	1.0B
Inventory	61.0M	38.2M	21.8M	15.7M	18.0M	17.1M
Non Current Liabilities Other	110.6M	190.8M	98.5M	62.9M	72.3M	70.3M
Intangible Assets	144.2M	108.1M	72.1M	36.0M	41.4M	39.4M
Current Deferred Revenue	15.2M	20.9M	3.7M	22.9M	20.6M	29.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CSX	CSX Corporation
ETON	Eton Pharmaceuticals
ALLT	Allot Communications

When determining whether Akebia Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Akebia Ther's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Akebia Ther Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Akebia Ther Stock:

How To Invest In Akebia

Details

Is Akebia Stock a good investment?

Details

What is Akebia Ther's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akebia Ther. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For information on how to trade Akebia Stock refer to our How to Trade Akebia Stock guide.

You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akebia Ther. If investors know Akebia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akebia Ther listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.22)

Revenue Per Share

0.834

Quarterly Revenue Growth

(0.11)

Return On Assets

(0.09)

Return On Equity

(5.53)

The market value of Akebia Ther is measured differently than its book value, which is the value of Akebia that is recorded on the company's balance sheet. Investors also form their own opinion of Akebia Ther's value that differs from its market value or its book value, called intrinsic value, which is Akebia Ther's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akebia Ther's market value can be influenced by many factors that don't directly affect Akebia Ther's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Akebia Ther's value and its price as these two are different measures arrived at by different means. Investors typically determine if Akebia Ther is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akebia Ther's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Akebia Capex To Operating Cash Flow vs Price To Sales Ratio Analysis

Capex To Operating Cash Flow vs Price To Sales Ratio

Capex To Operating Cash Flow vs Price To Sales Ratio Correlation Analysis

Correlation Coefficient

Capex To Operating Cash Flow

Price To Sales Ratio

Akebia Ther fundamental ratios Correlations

Akebia Ther Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Akebia Ther fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Accounts Payable	+ 0.98	Other Current Liab
Common Stock Shares Outstanding	+ 0.97	Common Stock Total Equity
Other Current Liab	+ 0.96	Total Assets
Short Term Debt	+ 0.96	Other Assets
Total Current Liabilities	+ 0.95	Other Current Liab
Non Current Assets Total	+ 0.95	Accounts Payable

Common Stock Shares Outstanding	- 0.96	Retained Earnings
Other Stockholder Equity	- 0.93	Retained Earnings
Short Long Term Debt Total	- 0.92	Retained Earnings
Common Stock Total Equity	- 0.92	Retained Earnings
Non Current Liabilities Total	- 0.91	Retained Earnings
Other Current Assets	- 0.89	Retained Earnings